{"id":46148,"date":"2025-04-02T10:50:00","date_gmt":"2025-04-02T07:50:00","guid":{"rendered":"https:\/\/denizcankizil.tr\/uncategorized-tr\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/"},"modified":"2025-04-02T10:50:00","modified_gmt":"2025-04-02T07:50:00","slug":"kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler","status":"publish","type":"post","link":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/","title":{"rendered":"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler"},"content":{"rendered":"

Kanser \u00e7a\u011f\u0131m\u0131z\u0131n hastal\u0131\u011f\u0131 ; 1-7 Nisan Kanserle Sava\u015f Haftas\u0131 gere\u011fince , kanserli hastalar\u0131n en b\u00fcy\u00fck sorunu olan ila\u00e7lara eri\u015fim hakk\u0131na, bu s\u00fcre\u00e7te ya\u015fad\u0131klar\u0131 zorluklara fark\u0131ndal\u0131k olu\u015fturmal\u0131y\u0131z.<\/p>\n

Kanser hastalar\u0131n\u0131n iyi bir tedavi yan\u0131nda, y\u00fcksek moral ve motivasyona ihtiyac\u0131n\u0131n oldu\u011fu bilinmektedir. Ancak \u00fclkemizde gerek ekonomik \u015fartlar\u0131n yetersizli\u011fi gerekse de kanserli vatanda\u015flar\u0131n temel ihtiya\u00e7lar\u0131 olan ila\u00e7lar\u0131na ula\u015fmak i\u00e7in ya\u015fad\u0131\u011f\u0131 maddi s\u0131k\u0131nt\u0131lar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, kanser hastalar\u0131n\u0131n moral ve motivasyon bulma ihtimali ekonomik sebepler nedeniyle olduk\u00e7a d\u00fc\u015fmektedir.<\/p>\n

Kanser tedavisinde kullan\u0131lan baz\u0131 ila\u00e7lar, Sosyal G\u00fcvenlik Kurumu (SGK) taraf\u0131ndan kar\u015f\u0131lanmamaktad\u0131r. Bu durum, hastalar\u0131n y\u00fcksek maliyetli tedavilere eri\u015fimini zorla\u015ft\u0131rmaktad\u0131r.<\/p>\n

Hastalar ila\u00e7lar\u0131n\u0131 dava yolu ile tedbir kararlar\u0131 ile almaya zorlanmaktad\u0131r.<\/p>\n

SGK taraf\u0131ndan kar\u015f\u0131lanmayan ila\u00e7lar\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in izlenebilecek hukuki ad\u0131mlar \u015funlard\u0131r:<\/p>\n

1. Hastane Raporu Al\u0131nmas\u0131: Tedaviyi \u00f6neren onkoloji doktorundan, kullan\u0131lacak ilac\u0131n bilgileri, dozu ve tedavi s\u00fcresini i\u00e7eren detayl\u0131 bir rapor al\u0131nmal\u0131d\u0131r. Bu rapor, ilac\u0131n hasta i\u00e7in t\u0131bbi gereklili\u011fini ve beklenen faydalar\u0131n\u0131 a\u00e7\u0131k\u00e7a belirtmelidir.<\/p>\n

2. Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Ba\u015fvurusu: E\u011fer ila\u00e7, T\u00fcrkiye’de onaylanm\u0131\u015f endikasyonlar d\u0131\u015f\u0131nda kullan\u0131lacaksa, doktorunuz arac\u0131l\u0131\u011f\u0131yla Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu’na endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m\u0131 i\u00e7in ba\u015fvuru yap\u0131lmas\u0131 gerekmektedir.<\/p>\n

Bu ba\u015fvuru, dava s\u00fcrecinde \u00f6nemli bir destekleyici unsur olacakt\u0131r.<\/p>\n

3. SGK’ya Ba\u015fvuru: \u0130lgili belgelerle birlikte, SGK’ya ilac\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in resmi bir ba\u015fvuru yap\u0131lmal\u0131d\u0131r. Bu ba\u015fvuru, hastan\u0131n kay\u0131tl\u0131 oldu\u011fu SGK \u0130l M\u00fcd\u00fcrl\u00fc\u011f\u00fc’ne yap\u0131l\u0131r. Yurt d\u0131\u015f\u0131ndan temin edilen ila\u00e7lar i\u00e7in Ankara Sosyal G\u00fcvenlik \u0130l M\u00fcd\u00fcrl\u00fc\u011f\u00fc’ne ba\u015fvurulmas\u0131 gerekmektedir.<\/p>\n

4. Dava A\u00e7\u0131lmas\u0131: SGK’n\u0131n ba\u015fvuruyu reddetmesi durumunda, idare mahkemesinde dava a\u00e7\u0131labilir. Dava s\u00fcrecinde, ilac\u0131n hayati \u00f6neme sahip oldu\u011funu ve alternatif tedavi se\u00e7eneklerinin yetersiz kald\u0131\u011f\u0131n\u0131 g\u00f6steren t\u0131bbi raporlar ve bilimsel makaleler sunulmal\u0131d\u0131r. Mahkeme, genellikle bu t\u00fcr davalarda bilirki\u015fi raporlar\u0131na dayanarak karar vermektedir.<\/p>\n

SGK, baz\u0131 kanser ila\u00e7lar\u0131n\u0131n bedelini belirli ko\u015fullar alt\u0131nda kar\u015f\u0131lamaktad\u0131r.<\/p>\n

Keytruda (Pembrolizumab): Malign melanom (deri kanseri) ve k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanseri tedavisinde SGK taraf\u0131ndan kar\u015f\u0131lanmaktad\u0131r. Di\u011fer kanser t\u00fcrleri i\u00e7in \u00f6deme yap\u0131lmamaktad\u0131r.<\/p>\n

Opdivo (Nivolumab): Malign melanom, renal h\u00fccreli karsinom ve klasik Hodgkin lenfoma tedavilerinde SGK taraf\u0131ndan kar\u015f\u0131lanmaktad\u0131r. Di\u011fer endikasyonlar i\u00e7in \u00f6deme yap\u0131lmamaktad\u0131r.<\/p>\n

Herceptin (Trastuzumab): Meme kanseri tedavisinde kullan\u0131lmas\u0131na ra\u011fmen, SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r. Bu nedenle hastalar hukuki yollara ba\u015fvurmaktad\u0131r.<\/p>\n

Altuzan (Bevacizumab): Kal\u0131n ba\u011f\u0131rsak kanseri tedavisinde kullan\u0131lmas\u0131na ra\u011fmen, SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r. \u0130lac\u0131n bedelinin \u00f6denmesi i\u00e7in dava a\u00e7\u0131lmas\u0131 gerekmektedir.<\/p>\n

Tecentriq (Atezolizumab): Akci\u011fer kanseri ve mesane kanseri tedavisinde kullan\u0131l\u0131r. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Trodelvy (Sacituzumab Govitecan): Meme kanseri ve idrar yollar\u0131 kanserlerinin tedavisinde etkilidir. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Zejula (Niraparib): Yumurtal\u0131k, fallop t\u00fcp\u00fc veya birincil periton kanseri tedavisinde kullan\u0131l\u0131r. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Mabthera (Rituksimab): Baz\u0131 lenfoma ve kan hastal\u0131klar\u0131n\u0131n tedavisinde kullan\u0131l\u0131r. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Enhertu (Trastuzumab Deruxtecan):\u00a0\u00a0Meme ve mide kanserlerinin tedavisinde etkilidir. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

\u200bKanser \u00e7a\u011f\u0131m\u0131z\u0131n hastal\u0131\u011f\u0131 ; 1-7 Nisan Kanserle Sava\u015f Haftas\u0131 gere\u011fince , kanserli hastalar\u0131n en b\u00fcy\u00fck sorunu olan ila\u00e7lara eri\u015fim hakk\u0131na, bu s\u00fcre\u00e7te ya\u015fad\u0131klar\u0131 zorluklara fark\u0131ndal\u0131k olu\u015fturmal\u0131y\u0131z.<\/p>\n

Kanser hastalar\u0131n\u0131n iyi bir tedavi yan\u0131nda, y\u00fcksek moral ve motivasyona ihtiyac\u0131n\u0131n oldu\u011fu bilinmektedir. Ancak \u00fclkemizde gerek ekonomik \u015fartlar\u0131n yetersizli\u011fi gerekse de kanserli vatanda\u015flar\u0131n temel ihtiya\u00e7lar\u0131 olan ila\u00e7lar\u0131na ula\u015fmak i\u00e7in ya\u015fad\u0131\u011f\u0131 maddi s\u0131k\u0131nt\u0131lar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, kanser hastalar\u0131n\u0131n moral ve motivasyon bulma ihtimali ekonomik sebepler nedeniyle olduk\u00e7a d\u00fc\u015fmektedir.<\/p>\n

Kanser tedavisinde kullan\u0131lan baz\u0131 ila\u00e7lar, Sosyal G\u00fcvenlik Kurumu (SGK) taraf\u0131ndan kar\u015f\u0131lanmamaktad\u0131r. Bu durum, hastalar\u0131n y\u00fcksek maliyetli tedavilere eri\u015fimini zorla\u015ft\u0131rmaktad\u0131r.<\/p>\n

Hastalar ila\u00e7lar\u0131n\u0131 dava yolu ile tedbir kararlar\u0131 ile almaya zorlanmaktad\u0131r.<\/p>\n

SGK taraf\u0131ndan kar\u015f\u0131lanmayan ila\u00e7lar\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in izlenebilecek hukuki ad\u0131mlar \u015funlard\u0131r:<\/p>\n

1. Hastane Raporu Al\u0131nmas\u0131: Tedaviyi \u00f6neren onkoloji doktorundan, kullan\u0131lacak ilac\u0131n bilgileri, dozu ve tedavi s\u00fcresini i\u00e7eren detayl\u0131 bir rapor al\u0131nmal\u0131d\u0131r. Bu rapor, ilac\u0131n hasta i\u00e7in t\u0131bbi gereklili\u011fini ve beklenen faydalar\u0131n\u0131 a\u00e7\u0131k\u00e7a belirtmelidir.<\/p>\n

2. Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Ba\u015fvurusu: E\u011fer ila\u00e7, T\u00fcrkiye’de onaylanm\u0131\u015f endikasyonlar d\u0131\u015f\u0131nda kullan\u0131lacaksa, doktorunuz arac\u0131l\u0131\u011f\u0131yla Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu’na endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m\u0131 i\u00e7in ba\u015fvuru yap\u0131lmas\u0131 gerekmektedir.<\/p>\n

Bu ba\u015fvuru, dava s\u00fcrecinde \u00f6nemli bir destekleyici unsur olacakt\u0131r.<\/p>\n

3. SGK’ya Ba\u015fvuru: \u0130lgili belgelerle birlikte, SGK’ya ilac\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in resmi bir ba\u015fvuru yap\u0131lmal\u0131d\u0131r. Bu ba\u015fvuru, hastan\u0131n kay\u0131tl\u0131 oldu\u011fu SGK \u0130l M\u00fcd\u00fcrl\u00fc\u011f\u00fc’ne yap\u0131l\u0131r. Yurt d\u0131\u015f\u0131ndan temin edilen ila\u00e7lar i\u00e7in Ankara Sosyal G\u00fcvenlik \u0130l M\u00fcd\u00fcrl\u00fc\u011f\u00fc’ne ba\u015fvurulmas\u0131 gerekmektedir.<\/p>\n

4. Dava A\u00e7\u0131lmas\u0131: SGK’n\u0131n ba\u015fvuruyu reddetmesi durumunda, idare mahkemesinde dava a\u00e7\u0131labilir. Dava s\u00fcrecinde, ilac\u0131n hayati \u00f6neme sahip oldu\u011funu ve alternatif tedavi se\u00e7eneklerinin yetersiz kald\u0131\u011f\u0131n\u0131 g\u00f6steren t\u0131bbi raporlar ve bilimsel makaleler sunulmal\u0131d\u0131r. Mahkeme, genellikle bu t\u00fcr davalarda bilirki\u015fi raporlar\u0131na dayanarak karar vermektedir.<\/p>\n

SGK, baz\u0131 kanser ila\u00e7lar\u0131n\u0131n bedelini belirli ko\u015fullar alt\u0131nda kar\u015f\u0131lamaktad\u0131r.<\/p>\n

Keytruda (Pembrolizumab): Malign melanom (deri kanseri) ve k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanseri tedavisinde SGK taraf\u0131ndan kar\u015f\u0131lanmaktad\u0131r. Di\u011fer kanser t\u00fcrleri i\u00e7in \u00f6deme yap\u0131lmamaktad\u0131r.<\/p>\n

Opdivo (Nivolumab): Malign melanom, renal h\u00fccreli karsinom ve klasik Hodgkin lenfoma tedavilerinde SGK taraf\u0131ndan kar\u015f\u0131lanmaktad\u0131r. Di\u011fer endikasyonlar i\u00e7in \u00f6deme yap\u0131lmamaktad\u0131r.<\/p>\n

Herceptin (Trastuzumab): Meme kanseri tedavisinde kullan\u0131lmas\u0131na ra\u011fmen, SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r. Bu nedenle hastalar hukuki yollara ba\u015fvurmaktad\u0131r.<\/p>\n

Altuzan (Bevacizumab): Kal\u0131n ba\u011f\u0131rsak kanseri tedavisinde kullan\u0131lmas\u0131na ra\u011fmen, SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r. \u0130lac\u0131n bedelinin \u00f6denmesi i\u00e7in dava a\u00e7\u0131lmas\u0131 gerekmektedir.<\/p>\n

Tecentriq (Atezolizumab): Akci\u011fer kanseri ve mesane kanseri tedavisinde kullan\u0131l\u0131r. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Trodelvy (Sacituzumab Govitecan): Meme kanseri ve idrar yollar\u0131 kanserlerinin tedavisinde etkilidir. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Zejula (Niraparib): Yumurtal\u0131k, fallop t\u00fcp\u00fc veya birincil periton kanseri tedavisinde kullan\u0131l\u0131r. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Mabthera (Rituksimab): Baz\u0131 lenfoma ve kan hastal\u0131klar\u0131n\u0131n tedavisinde kullan\u0131l\u0131r. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.<\/p>\n

Enhertu (Trastuzumab Deruxtecan):\u00a0\u00a0Meme ve mide kanserlerinin tedavisinde etkilidir. SGK taraf\u0131ndan bedeli kar\u015f\u0131lanmamaktad\u0131r.\u00a0Hukuki Haber<\/p>\n

Haberin Al\u0131nt\u0131land\u0131\u011f\u0131 Kaynak: www.hukukihaber.net<\/p>","protected":false},"excerpt":{"rendered":"

Kanser \u00e7a\u011f\u0131m\u0131z\u0131n hastal\u0131\u011f\u0131 ; 1-7 Nisan Kanserle Sava\u015f Haftas\u0131 gere\u011fince , kanserli hastalar\u0131n en b\u00fcy\u00fck sorunu olan ila\u00e7lara eri\u015fim hakk\u0131na, bu s\u00fcre\u00e7te ya\u015fad\u0131klar\u0131 zorluklara fark\u0131ndal\u0131k olu\u015fturmal\u0131y\u0131z. Kanser hastalar\u0131n\u0131n iyi bir tedavi yan\u0131nda, y\u00fcksek moral ve motivasyona ihtiyac\u0131n\u0131n oldu\u011fu bilinmektedir. Ancak \u00fclkemizde gerek ekonomik \u015fartlar\u0131n yetersizli\u011fi gerekse de kanserli vatanda\u015flar\u0131n temel ihtiya\u00e7lar\u0131 olan ila\u00e7lar\u0131na ula\u015fmak i\u00e7in ya\u015fad\u0131\u011f\u0131 maddi s\u0131k\u0131nt\u0131lar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, kanser hastalar\u0131n\u0131n moral ve motivasyon bulma ihtimali ekonomik sebepler nedeniyle olduk\u00e7a d\u00fc\u015fmektedir. Kanser tedavisinde kullan\u0131lan baz\u0131 ila\u00e7lar, Sosyal G\u00fcvenlik Kurumu (SGK) taraf\u0131ndan kar\u015f\u0131lanmamaktad\u0131r. Bu durum, hastalar\u0131n y\u00fcksek maliyetli tedavilere eri\u015fimini zorla\u015ft\u0131rmaktad\u0131r. Hastalar ila\u00e7lar\u0131n\u0131 dava yolu ile tedbir kararlar\u0131 ile almaya zorlanmaktad\u0131r. SGK taraf\u0131ndan kar\u015f\u0131lanmayan ila\u00e7lar\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in izlenebilecek hukuki ad\u0131mlar \u015funlard\u0131r: 1. Hastane Raporu Al\u0131nmas\u0131: Tedaviyi \u00f6neren onkoloji doktorundan, kullan\u0131lacak ilac\u0131n bilgileri, dozu ve tedavi s\u00fcresini i\u00e7eren detayl\u0131 bir rapor al\u0131nmal\u0131d\u0131r. Bu rapor, ilac\u0131n hasta i\u00e7in t\u0131bbi gereklili\u011fini ve beklenen faydalar\u0131n\u0131 a\u00e7\u0131k\u00e7a belirtmelidir. 2. Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Ba\u015fvurusu: E\u011fer ila\u00e7, T\u00fcrkiye’de onaylanm\u0131\u015f endikasyonlar d\u0131\u015f\u0131nda kullan\u0131lacaksa, doktorunuz arac\u0131l\u0131\u011f\u0131yla Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu’na endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m\u0131 i\u00e7in ba\u015fvuru yap\u0131lmas\u0131 gerekmektedir. Bu ba\u015fvuru, dava s\u00fcrecinde \u00f6nemli bir destekleyici unsur olacakt\u0131r. 3. SGK’ya Ba\u015fvuru: \u0130lgili belgelerle birlikte, SGK’ya ilac\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in resmi bir ba\u015fvuru yap\u0131lmal\u0131d\u0131r. Bu …<\/p>","protected":false},"author":3,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-46148","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hukukihaber"],"acf":[],"yoast_head":"\nKanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler - Av. Deniz Can K\u0131z\u0131l<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler\" \/>\n<meta property=\"og:description\" content=\"Kanser \u00e7a\u011f\u0131m\u0131z\u0131n hastal\u0131\u011f\u0131 ; 1-7 Nisan Kanserle Sava\u015f Haftas\u0131 gere\u011fince , kanserli hastalar\u0131n en b\u00fcy\u00fck sorunu olan ila\u00e7lara eri\u015fim hakk\u0131na, bu s\u00fcre\u00e7te ya\u015fad\u0131klar\u0131 zorluklara fark\u0131ndal\u0131k olu\u015fturmal\u0131y\u0131z. Kanser hastalar\u0131n\u0131n iyi bir tedavi yan\u0131nda, y\u00fcksek moral ve motivasyona ihtiyac\u0131n\u0131n oldu\u011fu bilinmektedir. Ancak \u00fclkemizde gerek ekonomik \u015fartlar\u0131n yetersizli\u011fi gerekse de kanserli vatanda\u015flar\u0131n temel ihtiya\u00e7lar\u0131 olan ila\u00e7lar\u0131na ula\u015fmak i\u00e7in ya\u015fad\u0131\u011f\u0131 maddi s\u0131k\u0131nt\u0131lar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, kanser hastalar\u0131n\u0131n moral ve motivasyon bulma ihtimali ekonomik sebepler nedeniyle olduk\u00e7a d\u00fc\u015fmektedir. Kanser tedavisinde kullan\u0131lan baz\u0131 ila\u00e7lar, Sosyal G\u00fcvenlik Kurumu (SGK) taraf\u0131ndan kar\u015f\u0131lanmamaktad\u0131r. Bu durum, hastalar\u0131n y\u00fcksek maliyetli tedavilere eri\u015fimini zorla\u015ft\u0131rmaktad\u0131r. Hastalar ila\u00e7lar\u0131n\u0131 dava yolu ile tedbir kararlar\u0131 ile almaya zorlanmaktad\u0131r. SGK taraf\u0131ndan kar\u015f\u0131lanmayan ila\u00e7lar\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in izlenebilecek hukuki ad\u0131mlar \u015funlard\u0131r: 1. Hastane Raporu Al\u0131nmas\u0131: Tedaviyi \u00f6neren onkoloji doktorundan, kullan\u0131lacak ilac\u0131n bilgileri, dozu ve tedavi s\u00fcresini i\u00e7eren detayl\u0131 bir rapor al\u0131nmal\u0131d\u0131r. Bu rapor, ilac\u0131n hasta i\u00e7in t\u0131bbi gereklili\u011fini ve beklenen faydalar\u0131n\u0131 a\u00e7\u0131k\u00e7a belirtmelidir. 2. Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Ba\u015fvurusu: E\u011fer ila\u00e7, T\u00fcrkiye’de onaylanm\u0131\u015f endikasyonlar d\u0131\u015f\u0131nda kullan\u0131lacaksa, doktorunuz arac\u0131l\u0131\u011f\u0131yla Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu’na endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m\u0131 i\u00e7in ba\u015fvuru yap\u0131lmas\u0131 gerekmektedir. Bu ba\u015fvuru, dava s\u00fcrecinde \u00f6nemli bir destekleyici unsur olacakt\u0131r. 3. SGK’ya Ba\u015fvuru: \u0130lgili belgelerle birlikte, SGK’ya ilac\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in resmi bir ba\u015fvuru yap\u0131lmal\u0131d\u0131r. Bu …\" \/>\n<meta property=\"og:url\" content=\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/\" \/>\n<meta property=\"og:site_name\" content=\"Av. Deniz Can K\u0131z\u0131l\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-02T07:50:00+00:00\" \/>\n<meta name=\"author\" content=\"Hukuki Haber.net\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hukuki Haber.net\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"6\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/\"},\"author\":{\"name\":\"Hukuki Haber.net\",\"@id\":\"http:\/\/denizcankizil.tr\/#\/schema\/person\/001a271de994a0aa3f90eea084424822\"},\"headline\":\"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler\",\"datePublished\":\"2025-04-02T07:50:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/\"},\"wordCount\":1289,\"publisher\":{\"@id\":\"http:\/\/denizcankizil.tr\/#organization\"},\"articleSection\":[\"Hukuki Haberler\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/\",\"url\":\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/\",\"name\":\"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler - Av. Deniz Can K\u0131z\u0131l\",\"isPartOf\":{\"@id\":\"http:\/\/denizcankizil.tr\/#website\"},\"datePublished\":\"2025-04-02T07:50:00+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/denizcankizil.tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/denizcankizil.tr\/#website\",\"url\":\"http:\/\/denizcankizil.tr\/\",\"name\":\"Av. Deniz Can K\u0131z\u0131l\",\"description\":\"Avukat Deniz Can K\u0131z\u0131l Antalya Barosu\",\"publisher\":{\"@id\":\"http:\/\/denizcankizil.tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/denizcankizil.tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"http:\/\/denizcankizil.tr\/#organization\",\"name\":\"Av. Deniz Can K\u0131z\u0131l\",\"url\":\"http:\/\/denizcankizil.tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"http:\/\/denizcankizil.tr\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/denizcankizil.tr\/wp-content\/uploads\/2024\/10\/siyah-logo-svg.svg\",\"contentUrl\":\"http:\/\/denizcankizil.tr\/wp-content\/uploads\/2024\/10\/siyah-logo-svg.svg\",\"width\":1080,\"height\":1080,\"caption\":\"Av. Deniz Can K\u0131z\u0131l\"},\"image\":{\"@id\":\"http:\/\/denizcankizil.tr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"http:\/\/denizcankizil.tr\/#\/schema\/person\/001a271de994a0aa3f90eea084424822\",\"name\":\"Hukuki Haber.net\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"http:\/\/denizcankizil.tr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/57d8a49151495586611a149d29fc42865b951dc053a84709a3172ccb5abf3118?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/57d8a49151495586611a149d29fc42865b951dc053a84709a3172ccb5abf3118?s=96&d=mm&r=g\",\"caption\":\"Hukuki Haber.net\"},\"sameAs\":[\"http:\/\/www.hukukihaber.net\"],\"url\":\"https:\/\/www.hukukihaber.net\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler - Av. Deniz Can K\u0131z\u0131l","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/","og_locale":"de_DE","og_type":"article","og_title":"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler","og_description":"Kanser \u00e7a\u011f\u0131m\u0131z\u0131n hastal\u0131\u011f\u0131 ; 1-7 Nisan Kanserle Sava\u015f Haftas\u0131 gere\u011fince , kanserli hastalar\u0131n en b\u00fcy\u00fck sorunu olan ila\u00e7lara eri\u015fim hakk\u0131na, bu s\u00fcre\u00e7te ya\u015fad\u0131klar\u0131 zorluklara fark\u0131ndal\u0131k olu\u015fturmal\u0131y\u0131z. Kanser hastalar\u0131n\u0131n iyi bir tedavi yan\u0131nda, y\u00fcksek moral ve motivasyona ihtiyac\u0131n\u0131n oldu\u011fu bilinmektedir. Ancak \u00fclkemizde gerek ekonomik \u015fartlar\u0131n yetersizli\u011fi gerekse de kanserli vatanda\u015flar\u0131n temel ihtiya\u00e7lar\u0131 olan ila\u00e7lar\u0131na ula\u015fmak i\u00e7in ya\u015fad\u0131\u011f\u0131 maddi s\u0131k\u0131nt\u0131lar\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, kanser hastalar\u0131n\u0131n moral ve motivasyon bulma ihtimali ekonomik sebepler nedeniyle olduk\u00e7a d\u00fc\u015fmektedir. Kanser tedavisinde kullan\u0131lan baz\u0131 ila\u00e7lar, Sosyal G\u00fcvenlik Kurumu (SGK) taraf\u0131ndan kar\u015f\u0131lanmamaktad\u0131r. Bu durum, hastalar\u0131n y\u00fcksek maliyetli tedavilere eri\u015fimini zorla\u015ft\u0131rmaktad\u0131r. Hastalar ila\u00e7lar\u0131n\u0131 dava yolu ile tedbir kararlar\u0131 ile almaya zorlanmaktad\u0131r. SGK taraf\u0131ndan kar\u015f\u0131lanmayan ila\u00e7lar\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in izlenebilecek hukuki ad\u0131mlar \u015funlard\u0131r: 1. Hastane Raporu Al\u0131nmas\u0131: Tedaviyi \u00f6neren onkoloji doktorundan, kullan\u0131lacak ilac\u0131n bilgileri, dozu ve tedavi s\u00fcresini i\u00e7eren detayl\u0131 bir rapor al\u0131nmal\u0131d\u0131r. Bu rapor, ilac\u0131n hasta i\u00e7in t\u0131bbi gereklili\u011fini ve beklenen faydalar\u0131n\u0131 a\u00e7\u0131k\u00e7a belirtmelidir. 2. Endikasyon D\u0131\u015f\u0131 \u0130la\u00e7 Ba\u015fvurusu: E\u011fer ila\u00e7, T\u00fcrkiye’de onaylanm\u0131\u015f endikasyonlar d\u0131\u015f\u0131nda kullan\u0131lacaksa, doktorunuz arac\u0131l\u0131\u011f\u0131yla Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu’na endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m\u0131 i\u00e7in ba\u015fvuru yap\u0131lmas\u0131 gerekmektedir. Bu ba\u015fvuru, dava s\u00fcrecinde \u00f6nemli bir destekleyici unsur olacakt\u0131r. 3. SGK’ya Ba\u015fvuru: \u0130lgili belgelerle birlikte, SGK’ya ilac\u0131n bedelinin kar\u015f\u0131lanmas\u0131 i\u00e7in resmi bir ba\u015fvuru yap\u0131lmal\u0131d\u0131r. Bu …","og_url":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/","og_site_name":"Av. Deniz Can K\u0131z\u0131l","article_published_time":"2025-04-02T07:50:00+00:00","author":"Hukuki Haber.net","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Hukuki Haber.net","Gesch\u00e4tzte Lesezeit":"6\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/#article","isPartOf":{"@id":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/"},"author":{"name":"Hukuki Haber.net","@id":"http:\/\/denizcankizil.tr\/#\/schema\/person\/001a271de994a0aa3f90eea084424822"},"headline":"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler","datePublished":"2025-04-02T07:50:00+00:00","mainEntityOfPage":{"@id":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/"},"wordCount":1289,"publisher":{"@id":"http:\/\/denizcankizil.tr\/#organization"},"articleSection":["Hukuki Haberler"],"inLanguage":"de"},{"@type":"WebPage","@id":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/","url":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/","name":"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler - Av. Deniz Can K\u0131z\u0131l","isPartOf":{"@id":"http:\/\/denizcankizil.tr\/#website"},"datePublished":"2025-04-02T07:50:00+00:00","breadcrumb":{"@id":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/denizcankizil.tr\/de\/hukukihaber\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/denizcankizil.tr\/"},{"@type":"ListItem","position":2,"name":"Kanser Hastalar\u0131n\u0131n \u0130la\u00e7lara Eri\u015fimi ve Hukuki S\u00fcre\u00e7ler"}]},{"@type":"WebSite","@id":"http:\/\/denizcankizil.tr\/#website","url":"http:\/\/denizcankizil.tr\/","name":"Av. Deniz Can K\u0131z\u0131l","description":"Avukat Deniz Can K\u0131z\u0131l Antalya Barosu","publisher":{"@id":"http:\/\/denizcankizil.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/denizcankizil.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"http:\/\/denizcankizil.tr\/#organization","name":"Av. Deniz Can K\u0131z\u0131l","url":"http:\/\/denizcankizil.tr\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"http:\/\/denizcankizil.tr\/#\/schema\/logo\/image\/","url":"http:\/\/denizcankizil.tr\/wp-content\/uploads\/2024\/10\/siyah-logo-svg.svg","contentUrl":"http:\/\/denizcankizil.tr\/wp-content\/uploads\/2024\/10\/siyah-logo-svg.svg","width":1080,"height":1080,"caption":"Av. Deniz Can K\u0131z\u0131l"},"image":{"@id":"http:\/\/denizcankizil.tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"http:\/\/denizcankizil.tr\/#\/schema\/person\/001a271de994a0aa3f90eea084424822","name":"Hukuki Haber.net","image":{"@type":"ImageObject","inLanguage":"de","@id":"http:\/\/denizcankizil.tr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/57d8a49151495586611a149d29fc42865b951dc053a84709a3172ccb5abf3118?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/57d8a49151495586611a149d29fc42865b951dc053a84709a3172ccb5abf3118?s=96&d=mm&r=g","caption":"Hukuki Haber.net"},"sameAs":["http:\/\/www.hukukihaber.net"],"url":"https:\/\/www.hukukihaber.net\/kanser-hastalarinin-ilaclara-erisimi-ve-hukuki-surecler"}]}},"_links":{"self":[{"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/posts\/46148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/comments?post=46148"}],"version-history":[{"count":0,"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/posts\/46148\/revisions"}],"wp:attachment":[{"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/media?parent=46148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/categories?post=46148"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/denizcankizil.tr\/de\/wp-json\/wp\/v2\/tags?post=46148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}